Active targeting schemes for nanoparticle systems in cancer therapeutics

被引:1356
作者
Byrne, James D. [1 ]
Betancourt, Tania [2 ]
Brannon-Peppas, Lisa [1 ,3 ]
机构
[1] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA
[2] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA
[3] Appian Labs, Austin, TX USA
关键词
Active targeting; Passive targeting; Cancer therapy; Angiogenesis; Nanoparticles; Targeting moiety;
D O I
10.1016/j.addr.2008.08.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this review is to outline current major cancer targets for nanoparticle systems and give insight into the direction of the field. The major targeting strategies that have been used for the delivery of therapeutic or imaging agents to cancer have been broken into three sections. These sections are angiogenesis-associated targeting, targeting to uncontrolled cell proliferation markers, and tumor cell targeting. The targeting schemes explored for many of the reported nanoparticle systems suggest the great potential of targeted delivery to revolutionize cancer treatment. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:1615 / 1626
页数:12
相关论文
共 143 条
  • [11] Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation:: preparation, characterization and in vitro evaluation
    Betancourt, Tania
    Brown, Brandon
    Brannon-Peppas, Lisa
    [J]. NANOMEDICINE, 2007, 2 (02) : 219 - 232
  • [12] A PEGylated dendritic nanoparticulate carrier of fluorouracil
    Bhadra, D
    Bhadra, S
    Jain, S
    Jain, NK
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) : 111 - 124
  • [13] Nanoparticle and targeted systems for cancer therapy
    Brannon-Peppas, L
    Blanchette, JO
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) : 1649 - 1659
  • [14] BROWN LF, 1993, CANCER RES, V53, P4727
  • [15] Therapeutic antibody fragments with prolonged in vivo half-lives
    Chapman, AP
    Antoniw, P
    Spitali, M
    West, S
    Stephens, S
    King, DJ
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (08) : 780 - 783
  • [16] PEGylated antibodies and antibody fragments for improved therapy: a review
    Chapman, AP
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (04) : 531 - 545
  • [17] Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy
    Chen, Huaiwen
    Gao, Jie
    Lu, Ying
    Kou, Geng
    Zhang, He
    Fan, Li
    Sun, Zhiguo
    Guo, Yajun
    Zhong, Yanqiang
    [J]. JOURNAL OF CONTROLLED RELEASE, 2008, 128 (03) : 209 - 216
  • [18] Molecular recognition of small-cell lung cancer cells using aptamers
    Chen, Hui William
    Medley, Colin D.
    Sefah, Kwame
    Shangguan, Dihua
    Tang, Zhiwen
    Meng, Ling
    Smith, Josh E.
    Tan, Weihong
    [J]. CHEMMEDCHEM, 2008, 3 (06) : 991 - 1001
  • [19] Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer
    Chen, J
    Wu, H
    Han, DY
    Xie, CS
    [J]. CANCER LETTERS, 2006, 231 (02) : 169 - 175
  • [20] Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery
    Cheng, Jianjun
    Teply, Benjamin A.
    Sherifi, Ines
    Sung, Josephine
    Luther, Gaurav
    Gu, Frank X.
    Levy-Nissenbaum, Etgar
    Radovic-Moreno, Aleksandar F.
    Langer, Robert
    Farokhzad, Omid C.
    [J]. BIOMATERIALS, 2007, 28 (05) : 869 - 876